Riccardo Lolatto

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Hepatitis C Virus

Acute Lymphoblastic Leukemia

Top Venues

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Tommaso Clemente, Laura Galli, Riccardo Lolatto, Roberta Gagliardini, Filippo Lagi, Micol Ferrara, Anna Maria Cattelan, Emanuele Foca', Antonio Di Biagio, Adriana Cervo, Leonardo Calza, Franco Maggiolo, Giulia Carla Marchetti, Giovanni Cenderello, Stefano Rusconi, Maurizio Zazzi, Maria-Mercedes Santoro, Vincenzo Spagnuolo, Antonella Castagna, null null
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors. BMJ open 14 (2) (2024)
Angelo Roberto Raccagni, Alessandro Mancon, Sara Diotallevi, Riccardo Lolatto, Elena Bruzzesi, Maria Rita Gismondo, Antonella Castagna, Davide Mileto, Silvia Nozza
Monkeypox Virus Neutralizing Antibodies at Six Months from Mpox Infection: Virologic Factors Associated with Poor Immunologic Response. Viruses 16 (5) (2024)
Tommaso Clemente, Laura Galli, Riccardo Lolatto, Roberta Gagliardini, Filippo Lagi, Micol Ferrara, Anna Maria Cattelan, Emanuele Foca', Antonio Di Biagio, Adriana Cervo, Leonardo Calza, Franco Maggiolo, Giulia Carla Marchetti, Giovanni Cenderello, Stefano Rusconi, Maurizio Zazzi, Maria-Mercedes Santoro, Vincenzo Spagnuolo, Antonella Castagna, null null
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors. BMJ open 14 (2) (2024)
Giulia Morsica, Emanuela Messina, Sabrina Bagaglio, Laura Galli, Riccardo Lolatto, Michela Sampaolo, Maxime Barakat, Robert J Israel, Antonella Castagna, Nicola Clementi
Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 Pneumonia. Microorganisms 12 (6) (2024)
Angelo Roberto Raccagni, Alessandro Mancon, Sara Diotallevi, Riccardo Lolatto, Elena Bruzzesi, Maria Rita Gismondo, Antonella Castagna, Davide Mileto, Silvia Nozza
Monkeypox Virus Neutralizing Antibodies at Six Months from Mpox Infection: Virologic Factors Associated with Poor Immunologic Response. Viruses 16 (5) (2024)
Giovanni Mori, Sara Diotallevi, Francesca Farina, Riccardo Lolatto, Laura Galli, Matteo Chiurlo, Andrea Acerbis, Elisabetta Xue, Daniela Clerici, Sara Mastaglio, Maria Teresa Lupo Stanghellini, Marco Ripa, Consuelo Corti, Jacopo Peccatori, Massimo Puoti, Bernardi Massimo, Antonella Castagna, Fabio Ciceri, Raffaella Greco, Chiara Oltolini
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies. Microorganisms 12 (1) (2024)
Giovanni Mori, Sara Diotallevi, Francesca Farina, Riccardo Lolatto, Laura Galli, Matteo Chiurlo, Andrea Acerbis, Elisabetta Xue, Daniela Clerici, Sara Mastaglio, Maria Teresa Lupo Stanghellini, Marco Ripa, Consuelo Corti, Jacopo Peccatori, Massimo Puoti, Bernardi Massimo, Antonella Castagna, Fabio Ciceri, Raffaella Greco, Chiara Oltolini
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies. Microorganisms 12 (1) (2024)
Giulia Morsica, Emanuela Messina, Sabrina Bagaglio, Laura Galli, Riccardo Lolatto, Michela Sampaolo, Maxime Barakat, Robert J Israel, Antonella Castagna, Nicola Clementi
Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 Pneumonia. Microorganisms 12 (6) (2024)
Angelo Roberto Raccagni, Alessandro Mancon, Sara Diotallevi, Riccardo Lolatto, Elena Bruzzesi, Maria Rita Gismondo, Antonella Castagna, Davide Mileto, Silvia Nozza
Monkeypox Virus Neutralizing Antibodies at Six Months from Mpox Infection: Virologic Factors Associated with Poor Immunologic Response. Viruses 16 (5) (2024)
Tommaso Clemente, Laura Galli, Riccardo Lolatto, Roberta Gagliardini, Filippo Lagi, Micol Ferrara, Anna Maria Cattelan, Emanuele Foca', Antonio Di Biagio, Adriana Cervo, Leonardo Calza, Franco Maggiolo, Giulia Carla Marchetti, Giovanni Cenderello, Stefano Rusconi, Maurizio Zazzi, Maria-Mercedes Santoro, Vincenzo Spagnuolo, Antonella Castagna, null null
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors. BMJ open 14 (2) (2024)
Giovanni Mori, Sara Diotallevi, Francesca Farina, Riccardo Lolatto, Laura Galli, Matteo Chiurlo, Andrea Acerbis, Elisabetta Xue, Daniela Clerici, Sara Mastaglio, Maria Teresa Lupo Stanghellini, Marco Ripa, Consuelo Corti, Jacopo Peccatori, Massimo Puoti, Bernardi Massimo, Antonella Castagna, Fabio Ciceri, Raffaella Greco, Chiara Oltolini
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies. Microorganisms 12 (1) (2024)
Tommaso Clemente, Laura Galli, Riccardo Lolatto, Roberta Gagliardini, Filippo Lagi, Micol Ferrara, Anna Maria Cattelan, Emanuele Foca', Antonio Di Biagio, Adriana Cervo, Leonardo Calza, Franco Maggiolo, Giulia Carla Marchetti, Giovanni Cenderello, Stefano Rusconi, Maurizio Zazzi, Maria-Mercedes Santoro, Vincenzo Spagnuolo, Antonella Castagna, null null
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors. BMJ open 14 (2) (2024)
Flavia Passini, Angelo Roberto Raccagni, Sara Diotallevi, Riccardo Lolatto, Elena Bruzzesi, Caterina Candela, Costanza Bertoni, Benedetta Trentacapilli, Maria Francesca Lucente, Antonella Castagna, Silvia Nozza
Mpox Outbreak 2022: A Comparative Analysis of the Characteristics of Individuals Receiving MVA-BN Vaccination and People Diagnosed with Mpox Infection in Milan, Italy. Pathogens (Basel, Switzerland) 12 (9) (2023)